Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilia Garlanda

Showing results (1-10 of 242) with videos related to

Pageof 25
Sort By:
Cancer Cell|May 14, 2021
Interleukin-1 in tumor progression, therapy, and preventionCecilia Garlanda, Alberto Mantovani
The New England Journal of Medicine|February 1, 2023
Humoral Innate Immunity and Acute-Phase ProteinsAlberto Mantovani, Cecilia Garlanda
Immunity|July 12, 2023
Genetics of autoinflammation instructs selective IL-1 targetingCecilia Garlanda, Domenico Supino
Cancer Immunology Research|June 23, 2021
Noncanonical Functions of C1s Complement Its Canonical Functions in Renal CancerElena Magrini, Cecilia Garlanda
Cancer Cell|February 6, 2026
Turn CAR T against TAMsAlberto Mantovani, Cecilia Garlanda
Trends in Immunology|September 26, 2024
COVID-19 thromboinflammation: adding inflammatory fibrin to the puzzleElena Magrini, Cecilia Garlanda
Nature Immunology|July 23, 2013
Platelet-macrophage partnership in innate immunity and inflammationAlberto Mantovani, Cecilia Garlanda
The New England Journal of Medicine|May 3, 2023
Humoral Innate Immunity and Acute-Phase Proteins. ReplyAlberto Mantovani, Cecilia Garlanda
Frontiers in Immunology|December 7, 2013
Ligands and receptors of the interleukin-1 family in immunity and diseaseCecilia Garlanda, Alberto Mantovani
Annals of Medicine|April 14, 2010
Molecular pathways and targets in cancer-related inflammationAlberto Mantovani, Cecilia Garlanda, Paola Allavena
Pageof 25

Showing results (1-10 of 242) with videos related to

Sort By:
Pageof 25
Cancer Cell|May 14, 2021
Interleukin-1 in tumor progression, therapy, and preventionCecilia Garlanda, Alberto Mantovani
The New England Journal of Medicine|February 1, 2023
Humoral Innate Immunity and Acute-Phase ProteinsAlberto Mantovani, Cecilia Garlanda
Immunity|July 12, 2023
Genetics of autoinflammation instructs selective IL-1 targetingCecilia Garlanda, Domenico Supino
Cancer Immunology Research|June 23, 2021
Noncanonical Functions of C1s Complement Its Canonical Functions in Renal CancerElena Magrini, Cecilia Garlanda
Cancer Cell|February 6, 2026
Turn CAR T against TAMsAlberto Mantovani, Cecilia Garlanda
Trends in Immunology|September 26, 2024
COVID-19 thromboinflammation: adding inflammatory fibrin to the puzzleElena Magrini, Cecilia Garlanda
Nature Immunology|July 23, 2013
Platelet-macrophage partnership in innate immunity and inflammationAlberto Mantovani, Cecilia Garlanda
The New England Journal of Medicine|May 3, 2023
Humoral Innate Immunity and Acute-Phase Proteins. ReplyAlberto Mantovani, Cecilia Garlanda
Frontiers in Immunology|December 7, 2013
Ligands and receptors of the interleukin-1 family in immunity and diseaseCecilia Garlanda, Alberto Mantovani
Annals of Medicine|April 14, 2010
Molecular pathways and targets in cancer-related inflammationAlberto Mantovani, Cecilia Garlanda, Paola Allavena
Pageof 25